People Background Check
Find People:

Venkata Karthikeswar Reddy PalleChandler, AZ

Get Report
Known as:
Venkata K Palle Venkata Karthikeswar Reddy Venkata R Pale Venkata K R Palls

Venkata Palle Phones & Addresses

Chandler, AZ

Fremont, CA

Milpitas, CA

Mentions for Venkata Karthikeswar Reddy Palle

Venkata Palle resumes & CV records

Resumes

Venkata Palle Photo 11

Tools Administrator Qa Lead

Location:
Chandler, AZ
Work:
Paypal
Tools Administrator Qa Lead
Education:
The School of Psychology, University of East London 2009 - 2011
Masters
Venkata Palle Photo 12

Venkata Palle

Publications & IP owners

Us Patents

N-Pyrazole A2A Adenosine Receptor Agonists

US Patent:
6403567, Jun 11, 2002
Filed:
Jun 22, 1999
Appl. No.:
09/338185
Inventors:
Jeff A. Zablocki - Mountain View CA
Elfatih O. Elzein - Freemont CA
Venkata P. Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 3170
US Classification:
514 46, 536 273, 536 276, 536 2761, 536 2762, 536 2763
Abstract:
2-adenosine N-pyrazole compositions having the following formula: and methods for using the compositions as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.

Thiophene A2A Receptor Agonists

US Patent:
6440948, Aug 27, 2002
Filed:
Jun 20, 2000
Appl. No.:
09/597436
Inventors:
Jeff A. Zablocki - Mountain View CA
Elfatih O. Elzein - Fremont CA
Venkata P. Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 3170
US Classification:
514 46, 536 2762
Abstract:
2-(3-,4-(substituted)-5-alkylthienyl)adenosines and the 5â-uronic acid amide analogues thereof having the following formula: are disclosed herein. Additionally disclosed are medicinal methods of treatment wherein the adenosine A agonist activity of the noted compounds stimulates mammalian coronary vasodilation for therapeutic purposes and for purposes of imaging the heart.

Substituted Alkyl Piperazine Derivatives

US Patent:
6451798, Sep 17, 2002
Filed:
Feb 22, 2001
Appl. No.:
09/792167
Inventors:
Vaibhav Varkhedkar - Sunnyvale CA
Venkata P. Palle - Mountain View CA
Jeff Zablocki - Mountain View CA
Elfatih Elzein - Fremont CA
Brent K. Blackburn - Los Altos CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425212, 544400
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Aralkyl Substituted Piperazine Compounds

US Patent:
6552023, Apr 22, 2003
Filed:
Feb 22, 2001
Appl. No.:
09/791133
Inventors:
Jeff Zablocki - Mountain View CA
Elfatih Elzein - Fremont CA
Brent K. Blackburn - Los Altos CA
Tim Marquart - San Francisco CA
Prabha N. Ibrahim - Mountain View CA
Venkata P. Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425212, 51425411, 544377, 544400
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Heteroaryl Alkyl Piperazine Derivatives

US Patent:
6573264, Jun 3, 2003
Filed:
Oct 23, 2000
Appl. No.:
09/694155
Inventors:
Jeff Zablocki - Mountain View CA
Prabha N. Ibrahim - Mountain View CA
Kevin Shenk - Palo Alto CA
Elfatih Elzein - Fremont CA
Venkata Palle - Mountain View CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31496
US Classification:
514249, 51425301, 51425306, 51425402, 51425409, 544354, 544360, 544363, 544368, 544373
Abstract:
Novel compounds of the general formula: and pharmaceutically acceptable acid addition salts thereof, wherein the compounds are useful in therapy to protect skeletal muscles against damage resulting from trauma or to protect skeletal muscles subsequent to muscle or systemic diseases such as intermittent claudication, to treat shock conditions, to preserve donor tissue and organs used in transplants, in the treatment of cardiovascular diseases including atrial and ventricular arrhythmias, Prinzmetals (variant) angina, stable angina, and exercise induced angina, congestive heart disease, and myocardial infarction.

Orally Active A1 Adenosine Receptor Agonists

US Patent:
6576619, Jun 10, 2003
Filed:
May 24, 1999
Appl. No.:
09/317523
Inventors:
Brent K. Blackburn - Los Altos CA
Chris Melville - Palo Alto CA
Jeff A. Zablocki - Mountain View CA
Venkata P. Palle - Mountain View CA
Elfaith O. Elzein - Freemont CA
Lisa Wang - Burlingame CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 3170
US Classification:
514 46, 536 276, 536 2762
Abstract:
Esters of N -oxa, thia, thioxa and azacycloalkyl substituted adenosine derivatives having the following formula; wherein the compounds are selective adenosine type 1 receptor agonists that are useful for the treatment cardiovascular diseases and central nervous system disorders.

Partial Or Full A1Agonists-N-6 Heterocyclic 5€²-Thio Substituted Adenosine Derivatives

US Patent:
6605597, Aug 12, 2003
Filed:
Dec 3, 1999
Appl. No.:
09/454136
Inventors:
Jeff A. Zablocki - Mountain View CA
Venkata P. Palle - Mountain View CA
Vaibhav Varkhedkar - Sunnyvale CA
Luiz Belardinelli - Menlo Park CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 5170
US Classification:
514 46, 536 273
Abstract:
N heterocyclic 5â modified adenosine derivatives that are adenosine A receptor partial or full agonists, and as such, are useful for modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals, and especially in humans.

2-(N-Pyrazolo)Adenosines With Application As Adenosine A2A Receptor Agonists

US Patent:
6642210, Nov 4, 2003
Filed:
Apr 12, 2002
Appl. No.:
10/018446
Inventors:
Jeff A. Zablocki - Mountain View CA
Elfatih O. Elzein - Freemont CA
Venkata P. Palle - Sunnyvale CA
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 3170
US Classification:
514 46, 5362263, 536 266, 536 2761, 536 2762, 536 2763
Abstract:
N-pyrazole substituted 2-adenosine compounds and methods for using the compounds as A A-adenosine receptor agonists useful to stimulate mammalian coronary vasodilation for therapeutic purposes and as adjuncts in cardiological imaging.

Possible Relatives

Venkata N Vemuri  Venkata K Gutta  Venkata D Kantamneni  Venkata A Kolli  Venkata S Vegesna  Venkata S Duvvuri 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.